Xtant Medical Holdings (XTNT) Gross Profit (2010 - 2025)

Xtant Medical Holdings (XTNT) has 16 years of Gross Profit data on file, last reported at $17.8 million in Q4 2025.

• Gross Profit for Q4 2025 came in at $17.8 million, up 10.8% year-over-year; the trailing twelve-month figure through Dec 2025 was $84.3 million (up 23.54% YoY), and the FY2025 annual result was $84.3 million, up 23.54% from the prior year.
• Gross Profit eased to $17.8 million in Q4 2025 per XTNT's latest filing, from $22.0 million in the prior quarter.
• Over five years, Gross Profit peaked at $24.3 million in Q2 2025 and troughed at $7.2 million in Q3 2021.
• A 5-year average of $13.6 million and a median of $13.9 million in 2023 frame the typical range for Gross Profit.
• The sharpest annual moves came in 2021 and 2023: Gross Profit dropped 22.24% in 2021, then soared 106.32% in 2023.
• A 5-year view of Gross Profit shows it stood at $7.7 million in 2021, then increased by 7.94% to $8.3 million in 2022, then soared by 106.32% to $17.1 million in 2023, then dropped by 6.49% to $16.0 million in 2024, then climbed by 10.8% to $17.8 million in 2025.
• Business Quant data shows XTNT's Gross Profit at $17.8 million in Q4 2025, $22.0 million in Q3 2025, and $24.3 million in Q2 2025.